Goldman Sachs Downgrades ResMed (RMD) to Neutral
Goldman Sachs downgraded ResMed (NYSE: RMD) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)